BRCA2 MUTATION
Clinical trials for BRCA2 MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRCA2 MUTATION trials appear
Sign up with your email to follow new studies for BRCA2 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat: new drug cocktail targets BRCA breast cancer
Disease control CompletedThis early-phase trial tested a combination of three drugs—olaparib, palbociclib, and fulvestrant—in 9 people with BRCA-mutated, hormone-positive, HER2-negative metastatic breast cancer. The main goal was to see if the combination is safe. Researchers also looked at how long the …
Matched conditions: BRCA2 MUTATION
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Toolkit aims to break the silence around inherited cancer genes
Knowledge-focused CompletedThis study tested whether a 'Disclosure Toolkit'—including a family letter, a chatbot, and a website—helps people with BRCA1 or BRCA2 mutations share their genetic test results with at-risk relatives. Researchers enrolled 52 participants to see if the toolkit improves communicati…
Matched conditions: BRCA2 MUTATION
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC